Lucid Diagnostics
LUCD
103 hedge funds and large institutions have $41M invested in Lucid Diagnostics in 2026 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 32 increasing their positions, 19 reducing their positions, and 11 closing their positions.
450% more capital inflows, than outflows
Capital inflows: $13.3M | Capital outflows: $2.42M
136% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 11
68% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 19
16% more funds holding
Funds holding: 89 → 103 (+14)
3.25% less ownership
Funds ownership: 23.37% → 20.13% (-3.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
+$2M |
| 2 |
Raymond James Financial
St Petersburg,
Florida
|
+$668K |
| 3 |
Sunbelt Securities
Houston,
Texas
|
+$657K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$452K |
| 5 |
BlackRock
New York
|
+$414K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$416K |
| 2 |
Luminus Management
Houston,
Texas
|
-$404K |
| 3 |
Jane Street
New York
|
-$395K |
| 4 |
Squarepoint
New York
|
-$290K |
| 5 |
Millennium Management
New York
|
-$181K |
LUCD Hedge Fund Activity: Q1 2026 in Review
103 of the 8,214 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q1 2026, worth a combined $41M — up 17% from $35.1M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new LUCD positions and 11 closed out — a net gain of 15 holders — while 32 added to existing stakes and 19 trimmed.
The largest buyer was Russell Investments Group, adding an estimated $2M. The largest seller was Renaissance Technologies, cutting an estimated $416K.
- 103 institutional investors held Lucid Diagnostics (LUCD) as of Q1 2026, up from 89 in Q4 2025.
- Funds reported $41M of Lucid Diagnostics stock for Q1 2026, up 17% quarter-over-quarter.
- 26 funds opened new Lucid Diagnostics positions in Q1 2026 and 11 closed out, a net change of +15 holders.
- The largest Lucid Diagnostics buyer in Q1 2026 was Russell Investments Group, an estimated $2M added.
- The largest Lucid Diagnostics seller in Q1 2026 was Renaissance Technologies, an estimated $416K sold.
Based on aggregated 13F filings for Q1 2026.